RESPIRATORY SYNCYTIAL VIRUS INFECTIONS+METAPNEUMOVIRUS

Clinical trials for RESPIRATORY SYNCYTIAL VIRUS INFECTIONS+METAPNEUMOVIRUS explained in plain language.

Never miss a new study

Get alerted when new RESPIRATORY SYNCYTIAL VIRUS INFECTIONS+METAPNEUMOVIRUS trials appear

Sign up with your email to follow new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTIONS+METAPNEUMOVIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Could one shot stop RSV and hMPV? GSK begins human trials

⭐️ VACCINE ⭐️ Not yet recruiting

This study tests an experimental vaccine from GSK that targets two respiratory viruses: RSV and hMPV. About 1,800 adults aged 18-80 will receive different doses to check safety and immune response. The goal is to see if a single shot can protect against both viruses, which can ca…

Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTIONS+METAPNEUMOVIRUS

Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️

Last updated Jun 27, 2026 13:02 UTC

RESPIRATORY SYNCYTIAL VIRUS INFECTIONS+METAPNEUMOVIRUS

Get alerted when new RESPIRATORY SYNCYTIAL VIRUS INFECTIONS+METAPNEUMOVIRUS trials appear

Could one shot stop RSV and hMPV? GSK begins human trials